June 2017

June 30, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) provides an update on financing activities.

Alliance Growers continues discussions with a private Streaming Finance Company that provides non-equity financing solutions for cannabis producers. Payments to the streaming company would be similar to a royalty, but based on a percentage of production rather than revenue.  The discussions include funding of the Cannabis Botany Centre as well as the 11,000-square foot production facility in Kelowna, British Columbia the Kelowna, currently under application with Health Canada.

On June 7, 2017, the Company announced our agreement with a German licensed producer applicant, Plantisaneco Gmbh (“Plantisaneco”), whereby Alliance Growers will earn a significant percentage of the equity in Plantisaneco in return for providing certain services and expertise. On the same day the partnership with Plantisaneco, Alliance Growers was approached by the private streaming company.

Alliance will be listing a Class A preferred shares as another non-dilutive financing mechanism.  A German financial institution has notified Alliance Growers that a proposal is being prepared for our review in the next two weeks.

Commenting on the financing options, Dennis Petke, Alliance Growers’ President and CEO commented, “Streaming financing looks like the best, most efficient non-dilutive financing option available to fund the Cannabis Botany Centre.  We are extremely pleased that we were approached by the streaming financing company.  We are very excited about the market potential for tissue cultured marijuana clone plantlets as we continue to confirm the numbers and contact growers to gauge the level of interest.  The streaming finance company we are working with has already partially financed a grow operation in Germany and we are confident that the cash flow potential of the Cannabis Botany Centre will be a good fit for the streaming financing model. We continue to build relationships within the investment community through continuous communication with brokers, streaming companies and financial institutions in North America and in Europe.  We are getting closer to finding the right combination and the right fit with the various financing sources and expect to fully finance all of our projects in the coming months.”

Market Potential for Tissue Cultured Marijuana Clone Plantlets

According to recent published data, dedicated grow-out space of the top 50 percent of Licensed ACMPR producers require 7,300,000 plants currently with ongoing expansion to 16,000,000 plants by 2019. The additional 50% of producers should add similar quantities bringing the total to 14,000,000 plants currently and with expansion estimated to be 32,000,000 plants required annually, by 2019. New licenses to be added by July 1st 2018 could push the number even higher to an estimated 22,000,000 plants required annually with expansion plans pushing out to over 40,000,000 marijuana plants to meet market supply.

The Cannabis Botany Centre is expected to produce and sell a minimum of 3,000,000 plantlets annually at a gross profit of $4.00 per plantlet for estimated gross profit of $12,000,000.  3,000,000 plantlets represents approximately 20% of the requirements of the top 50% of Licensed ACMPR producers and approximately 10% if all current Licensed ACMPR producers, including planned expansion.  Alliance Growers believes that tissue cultured marijuana clone plantlets will become the standard with Health Canada as we move toward legalization. https://www.newcannabisventures.com/tissue-culture-for-cannabis-cultivation-could-replace-cloning-as-the-gold-standard/.

About Plantisaneco

Plantisaneco is currently a license applicant under the Federal Institute for Drugs and Medical Devices, in the Federal State of Germany.  After the newly passed law for the prescription of medical cannabis and the loosening of the regulations that classified those people that are suffering as eligible, the estimated consumer market will grow rapidly to over 800,000 people within the next few years. To fill the demand, the federal agencies are seeking potential growers who will provide an excellent, high quality product. To benefit from the market opening, Plantisaneco is in the application process to obtain approval for growing licenses of up to 1400 KG of medical cannabis annually.

About Alliance Growers

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobDGrace@gmail.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 

 

 

 

 

 


June 29, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) announces updated potential market for tissue cultured marijuana clone plantlets to be produced at the Cannabis Botany Centre and an update on financing activities.

Alliance Growers is continually updating the potential market for tissue cultured marijuana clone plantlets utilizing published data of the annual plants required by licensed growers.  According to recent published data, dedicated grow-out space of the top 50 percent of Licensed ACMPR producers require 7,300,000 plants currently with ongoing expansion to 16,000,000 plants by 2019. The additional 50% of producers should add similar quantities bringing the total to 14,000,000 plants currently and with expansion estimated to be 32,000,000 plants required annually, by 2019. New licenses to be added by July 1st 2018 could push the number even higher to an estimated 22,000,000 plants required annually with expansion plans pushing out to over 40,000,000 marijuana plants to meet market supply.

The Cannabis Botany Centre is expected to produce and sell a minimum of 3,000,000 plantlets annually at a gross profit of $4.00 per plantlet for estimated gross profit of $12,000,000.  3,000,000 plantlets represents approximately 20% of the requirements of the top 50% of Licensed ACMPR producers and approximately 10% if all current Licensed ACMPR producers, including planned expansion.  Alliance Growers believes that tissue cultured marijuana clone plantlets will become the standard with Health Canada as we move toward legalization. https://www.newcannabisventures.com/tissue-culture-for-cannabis-cultivation-could-replace-cloning-as-the-gold-standard/.

To fund the Cannabis Botany Centre, Alliance Growers is in negotiations on two avenues of non-dilutive financing.  One being the issuance of Class A preferred shares as previously announced and the second with a Streaming company.  A German financial institution has notified Alliance Growers that a proposal is being prepared for our review within the coming two weeks.

On June 7, 2017, the Company announced our agreement with a German licensed producer applicant, Plantisaneco Gmbh (“Plantisaneco”), whereby Alliance Growers will earn a significant percentage of the equity in Plantisaneco in return for providing certain services and expertise.  On the same day as that announcement, Alliance Growers was approached by a private Streaming Finance Company that provides non-equity financing solutions for cannabis producers. The payments from Alliance Growers to the Streaming company would in a sense, be a form of royalty based on a percentage of production.  The discussions include funding the Cannabis Botany Centre as well as the 11,000-square foot production facility in Kelowna, British Columbia the Kelowna, currently under application with Health Canada.

Commenting on the financing options, Dennis Petke, Alliance Growers’ President and CEO commented, “We have been working diligently to provide the most efficient, non-dilutive financing options to fund our projects, especially the Botany Centre.  We are extremely pleased to be in discussions with the streaming financing company.  We are providing them with updated market potential numbers for their further review to estimate the cash flow potential of Cannabis Botany Centre.  The streaming finance company originally approached Alliance Growers about financing the Plantisaneco operation in Germany, as they have already partially financed a grow operation in that country.  Alliance Growers continues to build relationships within the investment community simultaneously through private placements, a Class A preferred share offering and now streaming financing.  We are getting closer to finding the right combination and the right fit with the various financing sources and expect to full finance all of our projects in the coming months.”.

About Plantisaneco

Plantisaneco is currently a license applicant under the Federal Institute for Drugs and Medical Devices, in the Federal State of Germany.  After the newly passed law for the prescription of medical cannabis and the loosening of the regulations that classified those people that are suffering as eligible, the estimated consumer market will grow rapidly to over 800,000 people within the next few years. To fill the demand, the federal agencies are seeking potential growers who will provide an excellent, high quality product. To benefit from the market opening, Plantisaneco is in the application process to obtain approval for growing licenses of up to 1400 KG of medical cannabis annually.

About Alliance Growers

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobDGrace@gmail.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 

 


June 7, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) is pleased to report that the Company is in the process of listing a second class of shares on the Canadian Stock Exchange (“CSE”) as part of the efforts to finance its projects.

As a result of interest from various Financial Institutions representing high net worth clients, the Company plans to list Class A preferred shares which are non-voting, non-convertible and with a dividend.  The proposed financing is preferred because Alliance Growers does not want existing shareholders to suffer the dilution that would result from investments of $5 million or higher.

Alliance Growers corporate material has been distributed to the parties who have expressed an interest in financing the Company under a preferred share issuance and we expect those entities to begin further due diligence in the near future.

Commenting on Alliances Growers’ new financing initiative, Dennis Petke, Alliance Growers’ President and CEO commented, “We are very pleased with the interest that we have received from these financial institutions.  We view the opportunity to capitalize on a non-dilutive, non-convertible financing as a stamp of approval on our Company’s strategy and business plan from the investment community. We will keep shareholders informed as the financing progresses.”

About Alliance Growers

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobDGrace@gmail.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 

 

 

 

 

 


June 7, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) announces that it has entered into an agreement with a German licensed producer applicant, Plantisaneco Gmbh (“Plantisaneco”), whereby Alliance Growers will earn a significant percentage of the equity in Plantisaneco in return for providing certain services and expertise.

No investment is required for the Company to earn its interest in Plantisaneco, and this strategic partnership contemplates securing long term tissue culture plantlet sale contracts for the Company’s Cannabis Botany Centre.

Alliance Growers’ participation has been included in Plantisaneco’s application filed with the Federal Institute for Drugs and Medical Devices in Germany on June 6, 2017.  Approximately 25 to 30 applications were submitted through a tender process whereby each applicant is allowed to apply for up to seven of the ten license contracts being awarded. Successful applicants will be chosen based on the quality of the growers, their experience in the industry, an excellent business plan, and adequate funding to support the implementation of the plan.  Plantisaneco applied for seven of the ten licenses to maximize its chances of success.  They have organized an efficient funding program with a high probability of success through a three stage process beginning with angel investors, followed by well researched grants and ultimately loans from German banking institutions who support this industry.

Alliance Growers is building a Global Cannabis company using a long-term strategy to create a strong company with consistent and growing cash flow with the least amount of regulatory and general business restrictions.  The arrangement with Plantisaneco augments the Company’s stated intent on the development of strategic partnerships with Licensed Producers and Licensed Producer applicants.  Alliance Growers’ and partner growers like Canwe, Plantisaneco and other growers will form business synergies with the goal of creating a strong presence in the fast-growing global medical cannabis space, including the purchase and sale between the parties of live cannabis plants, tissue culture plantlets and other cannabis growers’ products and services.

Commenting on Alliances Growers’ new partnership, Dennis Petke, Alliance Growers’ President and CEO commented, “We have been working diligently to develop significant and valuable strategic partnerships with existing Licensed Growers and Licensed Grower Applicants in connection with the Cannabis Botany Centre. We are exceptionally pleased with the alliance with Plantisaneco as this is our initial “foot in the door” to the European market which is expected to be extremely significant in the years to come.  Alliance is building relationships with the investment community simultaneously through a Class A preferred share offering which is expected to be very well received especially in light of this arrangement. Companies like Plantisaneco are a perfect fit with our long-term strategy for Alliance Growers to become a dominant player in the Cannabis space and successfully build strong shareholder value”.

About Plantisaneco

Plantisaneco is currently a license applicant under the Federal Institute for Drugs and Medical Devices, in the Federal State of Germany.  After the newly passed law for the prescription of medical cannabis and the loosening of the regulations that classified those people that are suffering as eligible, the estimated consumer market will grow rapidly to over 800,000 people within the next few years. To fill the demand, the federal agencies are seeking potential growers who will provide an excellent, high quality product. To benefit from the market opening, Plantisaneco is in the application process to obtain approval for growing licenses of up to 1400 KG of medical cannabis annually.

 About Alliance Growers

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobDGrace@gmail.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 

 

 

 

 

 


June 2, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) is pleased to report that the Company is diligently moving forward with its application to become a Licensed Producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The application is in process through subsidiary BC Maramed Production Ltd. (“BCMM”).

Health Canada has streamlined the application, effective May 26, 2017. The application process for becoming a licensed producer of cannabis for medical purposes is now as follows:

  1. Intake and Initial Screening
  2. Detailed Review and Initiation of Security Clearance Process
  3. Issuance of License to Produce
  4. Introductory Inspection (as cultivation begins)
  5. Pre-Sales Inspection
  6. Issuance of License to Sell

“We are thrilled by the streamlined application process that has been implemented by Health Canada and continue to be very optimistic on successfully completing the process. We believe that the new ACMPR procedures announced by Health Canada on May 26, 2017 will improve the Company’s prospect of obtaining a Cultivation License. We are committed to ensuring BCMM becomes a Licensed Producer and we are looking forward to getting positive, forward-moving updates from Health Canada,” said Dennis Petke, Alliance Growers’ President and CEO.

Alliance Growers currently holds a 50% interest in BCMM, which owns a leasehold interest and equipment for an 11,000-square foot production facility in Kelowna, British Columbia. One significant advantage of the BCMM site is that it already has a secured perimeter in place.  Pictures of the facility will be posted on the Alliance website in the next few days.

Alliance Growers is working with other shareholders of BCMM to ensure the site is secured and the ACMPR Application moves forward.  Part of the process will include engaging an external specialist to assist in successfully completing the application process.  The Company is confident that once it controls the application process, utilizing specialists with the required industry expertise combined with the high commercial standards of the production facility, the application will be in full compliance with Department of Health requirements for a full commercial ACMPR license.

Since filing its application to become a licensed producer in August 2014, BCMM has been diligently responding to numerous additional information requests by Health Canada.

As at October 9, 2015, Health Canada informed BCMM that its application was at Security Clearance Stage. During 2016, BCMM sought updates from Health Canada, as late as December 2016, and again in 2017.  BCMM will continue to seek updates from Health Canada regarding the status of its application and will update shareholders accordingly.  We expect that with the assistance of a specialist and the new streamlined rules, BCMM will be in a better position than ever before to be granted a license.

About Alliance Growers Corp.

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution,  and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com.

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobDGrace@gmail.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 


May 31, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) is pleased to announce the Company is negotiating terms to partner with Skill Gaming Inc. (“Skill”) to co-develop a cannabis marketplace app (“Canna App”).

On February 17, 2017, Alliance announced that the Company has been negotiating terms with a private BC Company to co-develop the Canna App.  Skill, a software development company brings the proven expertise to develop Canna App into a world class product in a cost effective and efficient manner.

The Canna App is designed to capitalize on the current and coming medical and recreational marijuana revolution. It is intended to mesh seamlessly with the products and services offered by the Alliance Cannabis Botany Centre.  It will provide a means for Growers and dispensaries to advertise products, facilitating sales and deliveries between Licensed Growers, dispensaries and customers, as well as aggregating social interactions. The marketplace will be also be user-content driven, allowing it to expand rapidly to meet market demands. The marketplace will be a full-service solution to sourcing, variety, selection, sales and delivery.

The Canna App will be a valuable tool for anybody involved in the cannabis industry, from growers to end users and all points in between. This would include providers of equipment for growing and extraction, plant nutrients, product packaging and other service providers in the industry.

The Canna App will position itself to be the eBay and Amazon of medical and recreational marijuana sales. Due to its user-driven model, the business will be able to expand into the national and international markets, wherever legally available.  The Canna App will also provide unique access to potential customers looking for services that are provided by the Alliance Cannabis Botany Centre.

Dennis Petke, Alliance Growers’ President and CEO, comments “We are pleased to be able to partner with Skill Gaming to co-develop the Canna App. The Canna App will be a valuable tool in the Cannabis space, allowing users to be able to locate local dispensaries, browse and search product catalogs, purchase and arrange delivery of products, comment on and rate products and businesses. Vendors will be able to list their dispensaries allowing users to locate it on a map, create and manage a business page with their own images and details, add or edit their list of products (marijuana strains, edible products, accessories), upload pictures of their business and products and reply to user comments. The Canna App fits perfectly with Alliance Growers’ strategy as we will be able to distribute pharmaceutical grade CBD oil to the various dispensaries as we develop that data base.  The development of the Canna App augments our strategy of setting the Company up for success by taking it to where the cannabis industry will be in the future.”

About Alliance Growers Corp.

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution,  and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

About Skill Gaming Inc.

Skill Gaming Inc. (“Skill”) is listed on the EURONEXT Exchange under the symbol MLSKL.  Skill represents the next generation of online gaming as the next up and coming name in skill gaming technology developers. Setting the standard for advanced software and intuitive user interfaces, Skill Gaming Inc. identifies the growth opportunities others miss. By challenging the way users view technology, Skill takes ideas and transforms them into practical everyday reality. The Company’s goal is to deliver value to the end user by combining groundbreaking concepts with world-class software development.

For further information please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobDGrace@gmailalliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.